Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Responsive Neurostimulation For Loss Of Control Eating

NCT: NCT03868670 · ACTIVE_NOT_RECRUITING

NCT IDNCT03868670
StatusACTIVE_NOT_RECRUITING
Start Date2019-04-10
Completion2028-01-01
SponsorUniversity of Pennsylvania (OTHER)
First posted
Last updated

Brief Summary

The primary objective of this trial is to assess device function and safety, with secondary objectives including the feasibility.

Frequently Asked Questions

What is Responsive Neurostimulation For Loss Of Control Eating?

Responsive Neurostimulation For Loss Of Control Eating is a clinical trial registered under NCT03868670. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT03868670?

The current status of NCT03868670 (Responsive Neurostimulation For Loss Of Control Eating) is: ACTIVE_NOT_RECRUITING.

When did Responsive Neurostimulation For Loss Of Control Eating start?

Responsive Neurostimulation For Loss Of Control Eating started on 2019-04-10.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑